Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 5
2005 5
2006 2
2007 3
2008 3
2009 1
2010 2
2011 3
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model.
Haga K, Takai-Todaka R, Matsumura Y, Song C, Takano T, Tojo T, Nagami A, Ishida Y, Masaki H, Tsuchiya M, Ebisudani T, Sugimoto S, Sato T, Yasuda H, Fukunaga K, Sawada A, Nemoto N, Murata K, Morimoto T, Katayama K. Haga K, et al. Among authors: tsuchiya m. PLoS Pathog. 2021 Oct 14;17(10):e1009542. doi: 10.1371/journal.ppat.1009542. eCollection 2021 Oct. PLoS Pathog. 2021. PMID: 34648602 Free PMC article.
A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand.
Yonehara R, Kumachi S, Kashiwagi K, Wakabayashi-Nakao K, Motohashi M, Murakami T, Yanagisawa T, Arai H, Murakami A, Ueno Y, Nemoto N, Tsuchiya M. Yonehara R, et al. Among authors: tsuchiya m. J Biol Chem. 2023 Feb;299(2):102804. doi: 10.1016/j.jbc.2022.102804. Epub 2022 Dec 15. J Biol Chem. 2023. PMID: 36529290 Free PMC article.
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells.
Nakano K, Orita T, Nezu J, Yoshino T, Ohizumi I, Sugimoto M, Furugaki K, Kinoshita Y, Ishiguro T, Hamakubo T, Kodama T, Aburatani H, Yamada-Okabe H, Tsuchiya M. Nakano K, et al. Among authors: tsuchiya m. Biochem Biophys Res Commun. 2009 Jan 9;378(2):279-84. doi: 10.1016/j.bbrc.2008.11.033. Epub 2008 Nov 18. Biochem Biophys Res Commun. 2009. PMID: 19022220
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer.
Ishiguro T, Sugimoto M, Kinoshita Y, Miyazaki Y, Nakano K, Tsunoda H, Sugo I, Ohizumi I, Aburatani H, Hamakubo T, Kodama T, Tsuchiya M, Yamada-Okabe H. Ishiguro T, et al. Among authors: tsuchiya m. Cancer Res. 2008 Dec 1;68(23):9832-8. doi: 10.1158/0008-5472.CAN-08-1973. Cancer Res. 2008. PMID: 19047163
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Hippo Y, Watanabe K, Watanabe A, Midorikawa Y, Yamamoto S, Ihara S, Tokita S, Iwanari H, Ito Y, Nakano K, Nezu J, Tsunoda H, Yoshino T, Ohizumi I, Tsuchiya M, Ohnishi S, Makuuchi M, Hamakubo T, Kodama T, Aburatani H. Hippo Y, et al. Among authors: tsuchiya m. Cancer Res. 2004 Apr 1;64(7):2418-23. doi: 10.1158/0008-5472.can-03-2191. Cancer Res. 2004. PMID: 15059894
27 results